Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.

PHASE3CompletedINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions

DiphtheriaHepatitis BHaemophilus Influenzae Type bWhole Cell PertussisTetanus

Interventions

BIOLOGICAL

DTPw-HBV/Hib-MenAC conjugate vaccine

Trial Locations (3)

GSK Investigational Site, Bangkok

GSK Investigational Site, Khon Kaen

GSK Investigational Site, Songkhla